Reports suggest a possible data breach involving NeoClinical in 2025; however, no official disclosure or report confirms this incident. Information regarding the nature of the breach, when it may have occurred, or who reported it, remains unclear.
The specific types of data that may have been exposed, the number of individuals potentially affected, and if any financial or medical data was involved has not been publicly confirmed. Available research points to Neoclinical Research operating clinical trial sites in several US states, including Florida, Illinois, Louisiana, Michigan, North Carolina, Ohio, and Tennessee, but these references do not mention any security incidents.
Details can emerge later, and official notices may be delayed.